|
Delayed
Liquidnet
05:13:53 2018-08-24 EDT
|
5-day change | 1st Jan Change | ||
| 14.34 EUR | -1.48% |
|
-.--% | - |
| 09-23 | AMS and Valeo lifted by brokers, Muse keeps the pressure on Orange | |
| 09-22 | French Telco Orange Invests in Health-tech Startup Biolevate | MT |
Company Valuation: Orange
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 24,775 | 24,661 | 27,400 | 25,593 | 37,752 | 37,634 | - | - |
| Change | - | -0.46% | 11.11% | -6.6% | 47.51% | -0.31% | - | - |
| Enterprise Value (EV) 1 | 49,044 | 49,959 | 54,402 | 48,075 | 60,278 | 76,472 | 75,040 | 73,009 |
| Change | - | 1.87% | 8.89% | -11.63% | 25.38% | 26.87% | -1.87% | -2.71% |
| P/E | - | 12.7x | 12.1x | 11.7x | 101x | 10.8x | 12.6x | 11.1x |
| PBR | 0.77x | 0.78x | 0.86x | 0.81x | 1.27x | 1.23x | 1.16x | 1.12x |
| PEG | - | - | 0.7x | -3.32x | -1.2x | 0x | -0.9x | 0.8x |
| Capitalization / Revenue | 0.58x | 0.57x | 0.62x | 0.64x | 0.93x | 0.83x | 0.77x | 0.75x |
| EV / Revenue | 1.15x | 1.15x | 1.23x | 1.19x | 1.49x | 1.69x | 1.53x | 1.46x |
| EV / EBITDA | 3.9x | 3.85x | 4.17x | 3.97x | 4.83x | 5.17x | 4.67x | 4.39x |
| EV / EBIT | 6.15x | 8.41x | 9.7x | 8.76x | 13.2x | 12.5x | 10.9x | 10.2x |
| EV / FCF | 13.7x | 12.9x | 10.4x | 12.8x | 13.2x | 16.1x | 14.3x | 12.9x |
| FCF Yield | 7.29% | 7.73% | 9.63% | 7.84% | 7.58% | 6.21% | 7% | 7.75% |
| Dividend per Share 2 | 0.7 | 0.7 | 0.7 | 0.72 | 0.75 | 0.7872 | 0.8196 | 0.8513 |
| Rate of return | 7.44% | 7.54% | 6.79% | 7.48% | 5.28% | 5.56% | 5.79% | 6.01% |
| EPS 2 | - | 0.73 | 0.85 | 0.82 | 0.14 | 1.306 | 1.122 | 1.274 |
| Distribution rate | - | 95.9% | 82.4% | 87.8% | 536% | 60.3% | 73% | 66.8% |
| Net sales 1 | 42,522 | 43,471 | 44,122 | 40,260 | 40,396 | 45,269 | 49,174 | 50,029 |
| EBITDA 1 | 12,566 | 12,963 | 13,035 | 12,109 | 12,470 | 14,779 | 16,075 | 16,635 |
| EBIT 1 | 7,969 | 5,943 | 5,610 | 5,489 | 4,568 | 6,112 | 6,894 | 7,151 |
| Net income 1 | 233 | 2,146 | 2,440 | 2,350 | 538 | 3,770 | 3,111 | 3,516 |
| Net Debt 1 | 24,269 | 25,298 | 27,002 | 22,482 | 22,526 | 38,838 | 37,406 | 35,375 |
| Reference price 2 | 9.41 | 9.28 | 10.30 | 9.63 | 14.20 | 14.16 | 14.16 | 14.16 |
| Nbr of stocks (in thousands) | 2,631,971 | 2,657,122 | 2,659,182 | 2,658,153 | 2,658,600 | 2,657,769 | - | - |
| Announcement Date | 2/17/22 | 2/16/23 | 2/15/24 | 2/13/25 | 2/18/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 10.96x | 1.29x | 4.1x | 7.08% | 221B | ||
| 10.41x | 2.5x | 6.6x | 5.99% | 196B | ||
| 13x | 2.12x | 5.47x | 4.18% | 148B | ||
| 13.84x | 1.86x | 8.12x | 3.03% | 91.12B | ||
| 11.54x | 0.88x | 3.29x | 6.69% | 79B | ||
| 11.58x | 1.78x | 4.5x | 2.82% | 66.07B | ||
| 14.96x | 2.66x | 8.3x | 5.11% | 57.48B | ||
| 23.05x | 5.24x | 19.11x | 4.74% | 54.68B | ||
| 14.87x | 2.75x | 6.11x | 4.38% | 51.37B | ||
| Average | 13.80x | 2.34x | 7.29x | 4.89% | 107.1B | |
| Weighted average by Cap. | 12.65x | 2.10x | 6.37x | 5.32% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ORA Stock
- FTE Stock
- Valuation Orange
Select your edition
All financial news and data tailored to specific country editions
















